Position: Director, Professor
Institution: Michael G. DeGroote Institute for Infectious Disease Research; Department of Biochemistry and Biomedical Sciences; Canada Research Chair in Antibiotic Biochemistry, McMaster University
City, Country: Hamilton, Otario, Canada
Role with AMR - One Health Consortium: Scientific Advisory Council Member
Dr. Gerry Wright received his BSc in Biochemistry (1986) and his PhD in Chemistry (1990) from the University of Waterloo working in the area of antifungal drugs under Dr John Honek. He followed this up with 2 years of postdoctoral research in Chris Walsh’s lab at Harvard Medical School in Boston where he worked on the molecular mechanism of resistance to the antibiotic vancomycin in enterococci. He joined the Department of Biochemistry at McMaster in 1993.
He holds the Michael G. DeGroote Chair in Infection and Anti-Infective Research and a Tier 1 Canada Research Chair in Antibiotic Biochemistry. From 2001-2007 Gerry served as Chair of the Department of Biochemistry and Biomedical Sciences at McMaster.
Gerry has served on grant panel advisory boards and Chaired grant panels for a number of funding agencies in Canada, the US, and Europe and consults widely for the pharmaceutical and biotech sectors.
He is the author of over 240 manuscripts and is a member of the editorial boards of several peer-reviewed journals including mBio, Antimicrobial Agents Chemotherapy, Cell Chemistry and Biology and the Journal of Antibiotics. He is an Associated Editor of ACS Infectious Diseases and Editor of Annals of the New York Academy of Sciences, Antimicrobial Therapeutics Reviews.
For more information on Dr. Wright's lab, visit the website below.